Kenacort Injection at a Glance
Kenacort Injection is a triamcinolone acetonide corticosteroid preparation manufactured by Abbott Healthcare Pvt. Ltd. This synthetic glucocorticoid formulation represents a well-established research tool for investigating anti-inflammatory mechanisms and steroid pharmacology in laboratory settings. Triamcinolone acetonide belongs to the intermediate-acting corticosteroid class, characterised by enhanced anti-inflammatory potency compared to hydrocortisone while maintaining reduced mineralocorticoid activity. Researchers at Stroid UK Shop can investigate this pharmaceutical-grade compound across diverse experimental protocols examining glucocorticoid receptor binding, inflammatory cascade modulation, and tissue-specific corticosteroid responses.
Laboratory Research Applications
This triamcinolone acetonide injection enables comprehensive studies into corticosteroid mechanisms of action, particularly focusing on NF-κB pathway inhibition and pro-inflammatory cytokine suppression in cell culture models. Research teams can examine glucocorticoid receptor translocation dynamics, phospholipase A2 inhibition pathways, and arachidonic acid cascade modulation using this standardised pharmaceutical preparation. The compound serves as an excellent reference standard for comparative corticosteroid studies alongside other anti-inflammatory agents available in our triamcinolone acetonide research collection. Investigators studying steroid pharmacokinetics can analyse this formulation’s absorption characteristics, tissue distribution patterns, and metabolic pathways in appropriate research models. The compound also facilitates research into glucocorticoid resistance mechanisms and receptor sensitivity variations across different tissue types.
Product Specifications
| Active Compound | Triamcinolone acetonide |
|---|---|
| Strength | 40 mg per injection |
| Manufacturer | Abbott Healthcare Pvt. Ltd. |
| Form | Injectable suspension |
| CAS Number | 76-25-5 |
| Molecular Formula | C₂₄H₃₁FO₆ |
| Storage | Refrigerate 2-8°C, protect from light |
Research teams can complement their corticosteroid investigations by exploring our comprehensive SARMS research compounds for comparative anti-inflammatory studies or examine our peptide collection for investigating alternative anti-inflammatory mechanisms in experimental protocols.
Research Compliance Statement
This Kenacort Injection is supplied exclusively for legitimate scientific research and in-vitro laboratory applications. This pharmaceutical preparation is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must comply with all applicable regulations governing corticosteroid research compounds and maintain appropriate institutional approvals for their experimental protocols. All investigations should follow established laboratory safety protocols when handling this research-grade corticosteroid formulation.
